Trial Profile
A Phase IV, Open-label, Non-randomized, Clinical Trial to Evaluate the Safety of Self-administered ADASUVE (Staccato Loxapine for Inhalation) in Agitated Patients Outside the Hospital Setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2020
Price :
$35
*
At a glance
- Drugs Loxapine (Primary)
- Indications Agitation
- Focus Adverse reactions
- Sponsors Ferrer
- 03 Nov 2020 Status changed from recruiting to completed.
- 06 Apr 2020 This trial has been completed in Norway, according to European Clinical Trials Database record.
- 03 Oct 2019 Planned End Date changed from 1 Dec 2019 to 1 Sep 2020.